Single Cell Technologies Define New Therapeutic Avenues for Huntington's Disease
- PMID: 32910889
- DOI: 10.1016/j.neuron.2020.08.007
Single Cell Technologies Define New Therapeutic Avenues for Huntington's Disease
Abstract
Using two independent single-cell transcriptomics technologies, Lee et al. have cataloged transcriptional changes in the subset of striatal neurons hit hardest in Huntington's disease. One downregulated pathway, oxidative phosphorylation, may also explain their observed release of mitochondrial-encoded RNAs.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment on
-
Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation.Neuron. 2020 Sep 9;107(5):891-908.e8. doi: 10.1016/j.neuron.2020.06.021. Epub 2020 Jul 17. Neuron. 2020. PMID: 32681824 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical